Progesterone resistance in endometriosis: origins, consequences and interventions

251Citations
Citations of this article
271Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Endometriosis is a common cause of pelvic pain and affects up to 10% of women of reproductive age. Aberrant progesterone signaling in the endometrium plays a significant role in impaired decidualization and establishment of ectopic endometrial implants. Eutopic endometrial cells from women with endometriosis fail to downregulate genes needed for decidualization, such as those involved in cell cycle regulation, leading to unbridled proliferation. Several causes of progesterone resistance in the endometrium have been postulated, including congenital “preconditioning”, whereby the in utero environment renders infants susceptible to neonatal uterine bleeding and endometriosis. Progesterone action is crucial to decreasing inflammation in the endometrium, and deviant progesterone signaling results in a proinflammatory phenotype. Conversely, chronic inflammation can induce a progesterone-resistant state. Repetitive retrograde endometrial shedding begets chronic peritoneal inflammation, which further exacerbates progesterone resistance. Genetic causes of progesterone resistance include progesterone receptor gene polymorphisms, altered microRNA expression, and epigenetic modifications to progesterone receptors and their targets. Environmental toxins such as dioxin play a possible role in the genesis of endometriosis by permitting an inflammatory milieu. A consequence of impaired progesterone action is that hormonal therapy is rendered ineffective for a subset of women with endometriosis. Synthetic progestins, such as dienogest, may overcome this phenomenon by increasing progesterone receptor expression and decreasing proinflammatory cytokines. Other modalities include high dose depot formulations of progestins, medicated intrauterine devices and the likely advent of oral GnRH antagonists. Unearthing root causes of progesterone inaction in endometriosis will aid in the development of novel therapeutics geared toward prevention and treatment.

References Powered by Scopus

MicroRNAs: Genomics, Biogenesis, Mechanism, and Function

32089Citations
N/AReaders
Get full text

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

1220Citations
N/AReaders
Get full text

Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis

654Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Endometriosis is a chronic systemic disease: clinical challenges and novel innovations

664Citations
N/AReaders
Get full text

The pathogenesis of endometriosis: Molecular and cell biology insights

362Citations
N/AReaders
Get full text

What exactly is endometrial receptivity?

292Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Patel, B. G., Rudnicki, M., Yu, J., Shu, Y., & Taylor, R. N. (2017, June 1). Progesterone resistance in endometriosis: origins, consequences and interventions. Acta Obstetricia et Gynecologica Scandinavica. Wiley-Blackwell. https://doi.org/10.1111/aogs.13156

Readers over time

‘17‘18‘19‘20‘21‘22‘23‘24‘25015304560

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 79

64%

Researcher 25

20%

Professor / Associate Prof. 14

11%

Lecturer / Post doc 5

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 77

55%

Biochemistry, Genetics and Molecular Bi... 42

30%

Nursing and Health Professions 10

7%

Agricultural and Biological Sciences 10

7%

Article Metrics

Tooltip
Mentions
News Mentions: 1
Social Media
Shares, Likes & Comments: 5

Save time finding and organizing research with Mendeley

Sign up for free
0